NUVAMA - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.8
| Stock Code | NUVAMA | Market Cap | 27,001 Cr. | Current Price | 1,480 ₹ | High / Low | 1,702 ₹ |
| Stock P/E | 47.6 | Book Value | 115 ₹ | Dividend Yield | 1.88 % | ROCE | 23.7 % |
| ROE | 28.2 % | Face Value | 2.00 ₹ | DMA 50 | 1,379 ₹ | DMA 200 | 1,350 ₹ |
| Chg in FII Hold | 0.55 % | Chg in DII Hold | -0.07 % | PAT Qtr | 19.1 Cr. | PAT Prev Qtr | 280 Cr. |
| RSI | 57.2 | MACD | 45.1 | Volume | 2,28,295 | Avg Vol 1Wk | 4,97,697 |
| Low price | 1,097 ₹ | High price | 1,702 ₹ | PEG Ratio | 0.14 | Debt to equity | 0.53 |
| 52w Index | 63.3 % | Qtr Profit Var | -30.4 % | EPS | 31.2 ₹ | Industry PE | 22.6 |
📊 Financials: The company shows decent profitability with ROE at 28.2% and ROCE at 23.7%, reflecting efficient capital usage. Debt-to-equity is moderate at 0.53, indicating manageable leverage. Quarterly PAT dropped sharply from ₹280 Cr. to ₹19.1 Cr., highlighting earnings volatility. EPS of ₹31.2 supports cash flow generation but remains modest relative to valuation.
💹 Valuation: Current P/E of 47.6 is significantly higher than the industry average of 22.6, suggesting overvaluation. The PEG ratio of 0.14 indicates strong growth prospects relative to price. Book value of ₹115 against a market price of ₹1,480 implies a stretched P/B ratio. Intrinsic value appears lower than current levels, requiring caution despite growth potential.
🏭 Business Model: The company operates in financial services and wealth management, benefiting from rising demand for investment advisory and brokerage services. Competitive advantage lies in brand recognition, distribution network, and institutional support, though profitability volatility remains a concern.
📈 Entry Zone: A favorable entry would be closer to ₹1,350–1,400, near the 200 DMA of ₹1,350. Current price of ₹1,480 is above fair value, so accumulation on dips is recommended.
⏳ Long-Term Holding: Strong fundamentals, institutional support, and sectoral demand make it suitable for long-term holding. However, stretched valuations and earnings volatility suggest cautious accumulation rather than aggressive buying.
Positive
- ✅ Strong ROE (28.2%) and ROCE (23.7%)
- ✅ EPS of ₹31.2 supports cash flow generation
- ✅ Dividend yield of 1.88% adds shareholder value
- ✅ Increase in FII (+0.55%) shows foreign investor confidence
Limitation
- ⚠️ Very high P/E (47.6) compared to industry average
- ⚠️ Stretched P/B ratio (Price ₹1,480 vs. Book Value ₹115)
- ⚠️ Sharp decline in quarterly PAT from ₹280 Cr. to ₹19.1 Cr.
Company Negative News
- 📉 Decline in DII holding (-0.07%) shows reduced domestic institutional confidence
- 📉 Quarterly PAT decline highlights earnings volatility
Company Positive News
- 📈 Increase in FII holding (+0.55%) reflects foreign investor interest
- 📈 RSI at 57.2 indicates neutral-to-positive momentum
Industry
- 💰 Financial services sector benefits from rising investment demand
- 📊 Industry P/E at 22.6 suggests peers are valued lower
- 🌍 Growth opportunities in wealth management, brokerage, and advisory services
Conclusion
Overall, the company is financially stable with strong return ratios and institutional support. However, stretched valuations and sharp earnings volatility limit upside potential. Best strategy is cautious accumulation near ₹1,350–1,400 for long-term holding, while avoiding aggressive buying at current levels.
Would you like me to extend this with a peer comparison against other financial service companies, or a technical analysis view to highlight support/resistance and momentum indicators?